Loading clinical trials...
Loading clinical trials...
A Multi-center, Single Arm, Safety and Efficacy Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation in Subjects With Relapsed or Refractory Peripheral T-cell Lymphoma
Conditions
Interventions
pralatrexate
Vitamin B12 and folic acid
Locations
1
China
Beijing Cancer Hospital
Beijing, China
Start Date
September 10, 2015
Primary Completion Date
July 21, 2017
Completion Date
May 21, 2018
Last Updated
October 1, 2019
NCT06909877
NCT05833724
NCT06855823
NCT05403450
NCT03278782
NCT03674411
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions